Account

Industry resources and insights

Sort by year
  • All time
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019 and older
Articles
19.05.2025
Avoiding Common Pitfalls in HTA Scientific Advice:...

With the implementation of the EU HTA (Regulation (EU) 2025/117) and ongoing adaptation of methods u...

Read more
Articles
12.05.2025
Driving Internal Alignment: How Early HTA Advice U...

As the regulatory and market access landscape continues to evolve across Europe, timely and strategi...

Read more
Articles
07.05.2025
Unlocking Payer Confidence: Why Early HTA Scientif...

In the current pharmaceutical environment, obtaining regulatory approval is no longer enough to ensu...

Read more
Insider Insights
28.04.2025
HTA Spotlight: First EU Joint Clinical Assessments...

The first joint clinical assessments under the new EU Health Technology Assessment (HTA) Regulation ...

Read more
Articles
23.04.2025
EU HTA Regulation for Medical Devices Starts in 20

The long-anticipated EU Health Technology Assessment (HTA) Regulation (Regulation (EU) 2021/2282) wa...

Read more
Insider Insights
14.04.2025
Reflections on the March 2025 EU HTA Webinar 

On 21 March 2025, the European Commission hosted a public webinar to share updates on the implementa...

Read more
Load more
Browse by topic
  • Biosimilars
  • Devices & Diagnostics
  • Digital Health
  • Early Access
  • Early Payer Dialogue
  • Emerging & Developing Markets
  • Funding
  • Gene Therapy & ATMPs
  • HTA
  • International Reference Pricing
  • Launch
  • Managed Entry Agreements
  • Medicine manufacturing
  • NICE
  • Oncology
  • Orphan Drugs
  • PMA Trends
  • Pricing
  • Rare Diseases
  • Real World Evidence
  • Team Remap
  • Tendering & Procurement
  • Training
Content type
  • All
  • Articles
  • Artificial Intelligence
  • Case Studies
  • China
  • Digital Health
  • Insider Insights
  • News
  • Pricing
  • Publications
  • Webinar
Subscribe
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.